Amylin Pharmaceuticals, Inc.

Astrazeneca Pharmaceuticals LP

Kevin D Laugero

David Geoffrey Parkes

Christine Marie Mack

Michael R Hanley

Andrew A Young

Christian Weyer

Paul McGonigle

Methods and compositions for treating psychiatric diseases and disorders are disclosed. The methods provided generally involve the administration of an amylin or an amylin agonist to a subject in order to treat psychiatric diseases and disorders, and conditions associated with psychiatric diseases and disorders.

Amylin and amylin agonists for treating psychiatric diseases and disorders

Methods and compositions for treating psychiatric diseases and disorders are disclosed. The methods provided generally involve the administration of an NMX peptide, an FNX peptide, or an NMX receptor agonist, or analogs or derivatives thereof, to a subject in order to treat psychiatric diseases and disorders, and conditions associated with psychiatric diseases and disorders.

Neuromedin and FN-38 peptides for treating psychiatric diseases

Compositions and methods for preventing, treating or controlling conditions or disorders associated with obesity, diet and nutrition are provided. The methods provided generally involve the administration of an Amylin or an Amylin agonist to a subject in order to prevent, treat or control conditions or disorders associated with obesity, diet and nutrition.

Method of modifying food preference comprising administering amylin or amylin agonist

Compositions and methods for preventing, treating or controlling conditions or disorders associated with obesity, diet, and nutrition are provided. The methods provided generally involve the administration of an amylin or an amylin agonist to a subject in order to prevent, treat or controlling conditions or disorders associated with obesity, diet, and nutrition.

Growing community of inventors

Davis, CA, United States of America

Kevin D Laugero